Steep Hill Inc. (STPH.CN) Research

Established in Toronto, Canada, in 2008, Steep Hill Inc. operates as a leading science and technology firm dedicated to the cannabis sector. The company delivers an extensive range of services throughout Canada and the United States, including sophisticated laboratory analysis, thorough quality assurance, and insightful data analytics. Its testing capabilities cover a broad spectrum, assessing cannabinoids, terpenes, pesticides, mycotoxins, heavy metals, and residual solvents. Additionally, Steep Hill conducts microbial examinations, foreign material screenings, and evaluates moisture levels, water activity, vitamin E acetate presence, and product uniformity, alongside comprehensive hemp assessments. Beyond its testing facilities, the organization offers specialized consulting regarding analytical methodologies, cannabis industry regulations, specific testing protocols, laboratory information management systems (LIMS), and overarching product integrity and safety. The entity rebranded to Steep Hill Inc. in February 2022, having previously operated as Cannabis Clonal Corporation.

Open Steep Hill Inc. (STPH.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.